Brief: Kane Biotech Announces 510(k) Submission For Its Coactiv+ Antimicrobial Hydrogel
03/11/2022 11:32
Nov 3 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES 510(K) SUBMISSION FOR ITS COACTIV+™
ANTIMICROBIAL HYDROGEL
Source text for Eikon: ID:nGNX9qJznc
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update